Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: The Japanese Musculoskeletal Oncology Group study

Đang chuẩn bị liên kết để tải về tài liệu:
Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: The Japanese Musculoskeletal Oncology Group study

Kim Tuyết 86 7 pdf

Giant cell tumor of the bone (GCTB) is classified as an intermediate, locally aggressive but rarely metastasizing tumor. The mainstay of treatment for the treatment of GCTB had been the surgical removal until an anti- receptor activator of nuclear factor-kappa B ligands (RANKL) antibody denosumab was developed. |

Đang chuẩn bị liên kết để tải về tài liệu:
Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: The Japanese Musculoskeletal Oncology Group study

Radiological changes do not influence clinical mid-term outcome in stemless humeral head replacements with hollow screw fixation: A prospective radiological and clinical evaluation

Follow-up score, change score or percentage change score for determining clinical important outcome following surgery? An observational study from the Norwegian registry for Spine surgery evaluating patient reported outcome measures in lumbar spinal stenosis and lumbar degenerative spondylolisthesis

Developing a risk prediction model for the functional outcome after hip arthroscopy

Factor analysis of the clinical outcomes in routine evaluation – outcome measures (CORE-OM) in a Kenyan sample

Isolated revision meniscal repair – failure rates, clinical outcome, and patient satisfaction

Functional outcome of total knee replacement: A study protocol for a prospective, double-blinded, parallel-group randomized, clinical controlled trial of novel, personalized and conventional implants

Consensus on draft OMERACT core domains for clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: A report from the International consensus on outcome measures in TJR trials (I-COMiTT) group

Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke

Trial registration and selective outcome reporting in 585 clinical trials investigating drugs for prevention of postoperative nausea and vomiting

Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib

Đang chuẩn bị liên kết để tải về tài liệu: Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: The Japanese Musculoskeletal Oncology Group study